Variant report
Variant | esv3445520 |
---|---|
Chromosome Location | chr2:186311707-186313605 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568031352 | chr2:186311748-186311749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75107439 | chr2:186311781-186311782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556906672 | chr2:186311791-186311792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575678659 | chr2:186311801-186311802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544468374 | chr2:186311822-186311823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114204720 | chr2:186311827-186311828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558286652 | chr2:186311843-186311844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184828601 | chr2:186311847-186311848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189392350 | chr2:186311928-186311929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556201078 | chr2:186311939-186311940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571827219 | chr2:186311946-186311947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377303794 | chr2:186311963-186311964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11675629 | chr2:186311990-186311991 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs544775305 | chr2:186312001-186312002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34853820 | chr2:186312032-186312033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554246813 | chr2:186312077-186312078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10931173 | chr2:186312108-186312109 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs145898358 | chr2:186312110-186312111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530623908 | chr2:186312119-186312120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551811015 | chr2:186312145-186312146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186106063 | chr2:186312182-186312183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190623744 | chr2:186312186-186312187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150961485 | chr2:186312238-186312239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11686861 | chr2:186312255-186312256 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs535418228 | chr2:186312264-186312265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545903989 | chr2:186312291-186312292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550743260 | chr2:186312308-186312309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11686896 | chr2:186312326-186312327 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs539628845 | chr2:186312334-186312335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs376844958 | chr2:186312403-186312404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs71011097 | chr2:186312426-186312427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4666686 | chr2:186312434-186312435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376246350 | chr2:186312435-186312436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367969571 | chr2:186312440-186312441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13022428 | chr2:186312480-186312481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12996661 | chr2:186312484-186312485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373392249 | chr2:186312491-186312492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531831702 | chr2:186312526-186312527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112663649 | chr2:186312530-186312531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201307504 | chr2:186312537-186312538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370215588 | chr2:186312538-186312539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71011098 | chr2:186312544-186312545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561141082 | chr2:186312675-186312676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111560775 | chr2:186312676-186312677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569967819 | chr2:186312694-186312695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs558247935 | chr2:186312779-186312780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573395243 | chr2:186312830-186312831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534159706 | chr2:186312840-186312841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555830480 | chr2:186312845-186312846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574263640 | chr2:186312927-186312928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186298200-186315800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr2:186298600-186315800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr2:186298800-186314800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr2:186301800-186316600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr2:186302000-186320200 | Weak transcription | HMEC | breast |
6 | chr2:186303000-186315600 | Weak transcription | NHEK | skin |
7 | chr2:186303200-186318200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr2:186309000-186314800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr2:186309400-186315000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr2:186312400-186315400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr2:186313600-186315800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |